Legal battles over abortion pill decision spark controversy.
TL;DR Summary
The Biden administration is seeking clarification on how to comply with two conflicting court orders on the abortion pill mifepristone. One ruling invalidated the FDA's approval of the drug, while the other directed the FDA to maintain access to it. The Justice Department and drugmaker Danco have asked a federal appeals court to freeze the ruling of the Texas-based judge who invalidated the FDA's approval. The legal turmoil may ultimately need to be resolved by the Supreme Court.
- Dueling abortion pill rulings put Biden administration in legal pickle POLITICO
- Pfizer CEO and Other Drug Company Leaders Condemn Texas Abortion Pill Ruling The New York Times
- AOC doubles down on 'ignoring' abortion rule, Clarence Thomas impeachment: 'abuse of judicial overreach' Fox News
- Opinion | Judge Kacsmaryk relied on ideology, not law, to block abortion drug The Washington Post
- Opinion | I Worked at the F.D.A. The Abortion Pill Decision Is Dangerous. The New York Times
Reading Insights
Total Reads
1
Unique Readers
8
Time Saved
3 min
vs 4 min read
Condensed
90%
774 → 78 words
Want the full story? Read the original article
Read on POLITICO